CLBTW (Cellebrite DI) Research & Development: $122.47 Mil (TTM As of Mar. 2026)


CLBTW Cellebrite DI Ltd CLBTW
84 GF Score
Price $5.25
! 3 Warning Signs
View Full Analysis

What is Cellebrite DI Research & Development?

Cellebrite DI CLBTW 84 Research & Development is $122.47 Mil as of Mar. 2026. GuruFocus rates CLBTW with a GF Score™ of 84/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cellebrite DI's Research & Development for the three months ended in Mar. 2026 was $35.87 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $122.47 Mil.


Cellebrite DI  (NAS:CLBTW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Cellebrite DI Research & Development Related Terms


Cellebrite DI Research & Development Historical Data

* Premium members only.

The historical data trend for Cellebrite DI's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellebrite DI Research & Development Chart

Cellebrite DI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 65.54 80.62 84.39 98.42 113.88

Cellebrite DI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.28 28.61 28.12 29.87 35.87
CLBTW
84GF Score
Cellebrite DI Ltd CLBTW
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellebrite DI Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $122.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $122.47 Mil mean?
Cellebrite DI (CLBTW) has a Research & Development of $122.47 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Cellebrite DI and its competitors.
Is Cellebrite DI's Research & Development too high?
Cellebrite DI's current Research & Development is $122.47 Mil. Overall, Cellebrite DI has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's Research & Development compare to BOX and INFQ?
Cellebrite DI's Research & Development of $122.47 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cellebrite DI and its competitors. Cellebrite DI's current Research & Development is $122.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Cellebrite DI (CLBTW) has a current Research & Development of $122.47 Mil. The current Research & Development is $122.47 Mil. Cellebrite DI's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cellebrite DI (CLBTW), the current Research & Development is $122.47 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellebrite DI Business Description

Other Exchanges CLBT:USA9W9:Germany
Address 94 Shlomo Shmelzer Road, P.O. Box 3925, Petah Tikva, ISR, 4970602
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
84GF Score

Get the complete analysis for CLBTW

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.25
Price